In a groundbreaking achievement, a multidisciplinary team at the Army Hospital (Research and Referral) has successfully performed therapeutic plasma exchange (TPE) on an 18-month-old child diagnosed with hyper-acute Guillain-Barré syndrome (GBS). This marks the youngest recorded case of its kind in the history of the Armed Forces Medical Services.
Guillain-Barré syndrome is a rare and potentially life-threatening autoimmune disorder where the body’s immune system attacks peripheral nerves, often leading to rapid-onset paralysis. According to the National Health Service (NHS), the mortality rate can reach 5%, making early intervention critical.
The TPE procedure, conducted in the hospital’s advanced intensive care unit, involved removing harmful antibodies from the child’s bloodstream to halt the progression of the disease. Studies published in the Journal of Clinical Apheresis (2020) have shown that timely TPE can improve recovery outcomes in up to 70% of GBS cases.
The procedure required a coordinated effort by a specialized team from the Department of Pediatrics, using highly sophisticated equipment and protocols adapted for pediatric care. The child’s recovery challenges the conventional prognosis for such a young GBS patient and highlights the hospital’s advanced capability in pediatric neurology.
This milestone not only brings hope to families dealing with similar diagnoses but also cements Army Hospital (R&R)’s reputation as a national leader in complex, high-stakes medical interventions.
